A biostatician with deep NIH and FDA ties talks about general guidelines for changing primary end points. Plus, the M-word. more...

Inspired by Web 2.0 tools that foster sharing and collaboration, Insightful Software released new software to generate charts and graphs in a regulated setting. more...

A Japanese pharma talks about patient diaries and biostatistical concerns. more...

Could the best-laid plans for adaptive trials have unexpected results? more...

United BioSource talks about resources (its own and others) for adaptive trials. more...

Clinical sites have it rough, and numbers from the Tufts Center for Drug Development show few heartening trends. more...

Cytel and Tourtellotte Consulting join forces to design trials and drug supply needs for adaptive protocols. more...

As life science organizations consider adaptive clinical trial designs, the process, technology and operational aspects are complex. What to consider. more...

Can your clinical data warehouse combine genotyping data, clinical data and demographic data? And analyze it in a reproducible way? A conversation with Waban. more...

Cytel and Tourtellotte consulting have integrated two important applications. more...

In describing a new Phase III trial, Napo Pharmaceuticals touts its adaptive approach. Will other sponsors stoke investor interest using the anticipation surrounding adaptive trials? more...

The Canadian EDC supplier offers a true zero-footprint offering, with benefits in speed and user-friendliness. The company believes it is especially well-positioned to handle trials in different regulatory jurisdictions. more...

The founder of a SAS-based clinical data management system talks about clinical data management and standards. more...

A discussion about infrastructure for adaptive clinical trials. With process change and the right technology, Cytel‘s Jerry Schindler says, pharma could wring significant savings out of clinical development. more...

In addition to embarking on a rapid adoption of an adaptive design, the biotech company is making an unusually swift and public acknowlegment of an innovative strategy. more...

Fascinating Wall Street Journal coverage of instruments and software from Affy, Illumina.  And a note about Insightful Software tools to help sort off what comes of such equipment. more...